Law360

Publish Date
Ex-USPTO Directors Rally Against WTO IP Waiver

Former U.S. Patent and Trademark Office directors and several prominent patent lawyers are among those telling the Biden administration not to side...

Law360
Andrew Karpan
Transparency, Injunctions Dominate SEP Feedback
Law360
Dani Kass
Here’s What’s To Come In Fight Over Apple Watch Import Ban
Law360
Ryan Davis
Ex-USPTO Head Says Breaking Patents Won’t Cut Drug Prices
Law360
Andrew Karpan
2 Reps. Float House Companion To Senate PTAB Overhaul Bill
Law360
Ryan Davis
3 Ways New Senate Bill Would Reshape PTAB Litigation
Law360
Ryan Davis
PTAB Proposals Spur Concern About New Limits And Legality
Law360
Ryan Davis and Dani Kass
IP Group Names Congressional Atty As Counsel, Policy Exec
Law360
Jack Rodgers
Ex-US Officials Slam EU Standard-Essential Patent Draft Rules
Law360
Adam Lidgett
Ex-USPTO Chiefs Say Patent System ‘Overhaul’ Not Needed
Law360
Adam Lidgett
Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver
Law360
Britain Eakin
Congress Should Pass Tillis-Coons Patent Eligibility Bill
Law360
Paul Michel and Katheleen O 'Malley
News:

News:

Ex-USPTO Directors Rally Against WTO IP Waiver,

12/06/2023

News:

News:

Transparency, Injunctions Dominate SEP Feedback,

11/08/2023

News:

News:

Here’s What’s To Come In Fight Over Apple Watch Import Ban,

10/31/2023

News:

News:

Ex-USPTO Head Says Breaking Patents Won’t Cut Drug Prices,

09/29/2023

News:

News:

2 Reps. Float House Companion To Senate PTAB Overhaul Bill,

06/27/2023

News:

News:

3 Ways New Senate Bill Would Reshape PTAB Litigation,

06/26/2023

News:

News:

PTAB Proposals Spur Concern About New Limits And Legality,

06/22/2023

News:

News:

IP Group Names Congressional Atty As Counsel, Policy Exec,

04/26/2023

News:

News:

Ex-US Officials Slam EU Standard-Essential Patent Draft Rules,

04/21/2023

News:

News:

Ex-USPTO Chiefs Say Patent System ‘Overhaul’ Not Needed,

02/02/2023

News:

News:

Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver,

12/01/2022

Op-Eds:

Op-Eds:

Congress Should Pass Tillis-Coons Patent Eligibility Bill,

11/18/2022

Scroll to Top